Pancreatic cancer: Incidence, treatment and survival trends - 1175 cases in Calvados (France) from 1978 to 2002

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 10-11, 2009, Pages 1045-1051

  Lefebvre, A C ^a   Maurel, J ^b   Boutreux, S ^b   Bouvier, V ^b   Reimund, J M ^a   Launoy, G ^b   Arsene, D ^a  

^a CHU CÔTE DE NACRE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY;

AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 70350621771     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.04.011     Document Type: Article

References (45)

1. Barthet M., Moutardier V., and Marciano S. Adenocarcinomas of the pancreas: how best to evaluate respectability?. Gastroenterol Clin Biol 31 (2007) 216-221
2. Rafique A., Freeman S., and Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin Radiol 62 (2007) 1142-1153
3. Sahani D.V., Shah Z.K., Catalano O.A., Boland G.W., and Brugge W.R. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23 (2008) 23-33
4. Wakabayashi H., Nishiyama Y., Otani T., Sano T., Yachida S., Okano K., et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 14 (2008) 64-69
5. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 (2008) 1345-1389
6. Garcea G., Dennison A.R., Pattenden C.J., Neal C.P., Sutton C.D., and Berry D.P. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 9 (2008) 99-132
7. Mitry E., Rachet B., Quinn M.J., Cooper N., and Coleman M.P. Survival from cancer of the pancreas in England and Wales up to 2001. Br J Cancer 99 Suppl. 1 (2008) S21-S23
8. Sant M., Aareleid T., Berrino F., Bielska L.M., Carli P.M., Faivre J., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol 14 Suppl. 5 (2003) v61-118
9. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., and Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45 (2009) 931-991
10. Bossard N., Velten M., Remontet L., Belot A., Maarouf N., Bouvier A.M., et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43 (2007) 149-160
11. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56 (2008) 159-175
12. Bray F., Sankila R., Ferlay J., and Parkin D.M. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38 (2002) 99-166
13. Cress R.D., Yin D., Clarke L., Bold R., and Holly E.A. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 17 (2006) 403-409
14. de Braud F., Cascinu S., and Gatta G. Cancer of pancreas. Crit Rev Oncol Hematol 50 (2004) 147-155
15. Lankisch P.G., Assmus C., Maisonneuve P., and Lowenfels A.B. Epidemiology of pancreatic diseases in Luneburg County. A study in a defined german population. Pancreatology 2 (2002) 469-477
16. Lowenfels A.B., and Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 197-209
17. Lowenfels A.B., and Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34 (2004) 238-244
18. Sener S.F., Fremgen A., Menck H.R., and Winchester D.P. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189 (1999) 1-7
19. Moutet J.P., Arveux P., Kurdi E., Hillon P., and Faivre J. Incidence, diagnosis, treatment and prognosis of cancer of the pancreas: development in Cote-d'Or from 1976 to 1985. Bull Cancer 78 (1991) 323-330
20. Bramhall S.R., Allum W.H., Jones A.G., Allwood A., Cummins C., and Neoptolemos J.P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82 (1995) 111-115
21. National Cancer Institute. Surveillance Epidemiology and End Results: cancer of the pancreas 2005.
22. Alexakis N., Halloran C., Raraty M., Ghaneh P., Sutton R., and Neoptolemos J.P. Current standards of surgery for pancreatic cancer. Br J Surg 91 (2004) 1410-1427
23. Hedberg M., Borgstrom A., Genell S., and Janzon L. Survival following pancreatic carcinoma: a follow-up study of all cases recorded in Malmo, Sweden, 1977-1991. Br J Surg 85 (1998) 1641-1644
24. Neoptolemos J.P., Russell R.C., Bramhall S., Theis B., and UK Pancreatic Cancer Group. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br J Surg 84 (1997) 1370-1376
25. Pasquali C., Sperti C., Filipponi C., and Pedrazzoli S. Epidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival (1990-1992). Dig Liver Dis 34 (2002) 723-731
26. Yeo C.J., Cameron J.L., Lillemoe K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-731
27. Andersen J.R., Sorensen S.M., Kruse A., Rokkjaer M., and Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 30 (1989) 1132-1135
28. Johnsson E., Thune A., and Liedman B. Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg 28 (2004) 812-817
29. Raikar G.V., Melin M.M., Ress A., Lettieri S.Z., Poterucha J.J., Nagorney D.M., et al. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncol 3 (1996) 470-475
30. Shepherd H.A., Royle G., Ross A.P., Diba A., Arthur M., and Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 75 (1988) 1166-1168
31. Smith A.C., Dowsett J.F., Russell R.C., Hatfield A.R., and Cotton P.B. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 344 (1994) 1655-1660
32. Burris III H.A., Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
33. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
34. Klinkenbijl J.H., Jeekel J., Sahmoud T., van Pel R., Couvreur M.L., Veenhof C.H., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782
35. Neoptolemos J.P., Stocken D.D., Friess H., Bassi C., Dunn J.A., Hickey H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
36. Oettle H., Post S., Neuhaus P., Gellert K., Langrehr J., Ridwelski K., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
37. Saif M.W. Controversies in the adjuvant treatment of pancreatic adenocarcinoma. JOP 8 (2007) 545-552
38. Bakkevold K.E., Arnesjo B., Dahl O., and Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study. Eur J Cancer 29A (1993) 698-703
39. Cullinan S., Moertel C.G., Wieand H.S., Schutt A.J., Krook J.E., Foley J.F., et al. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 65 (1990) 2207-2212
40. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59 12 (1987) 2006-2010
41. Buchler M.W., Wagner M., Schmied B.M., Uhl W., Friess H., and Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003) 1310-1314
42. Seiler C.A., Wagner M., Bachmann T., Redaelli C.A., Schmied B., Uhl W., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
43. Stojadinovic A., Brooks A., Hoos A., Jaques D.P., Conlon K.C., and Brennan M.F. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 196 (2003) 954-964
44. Tran K.T., Smeenk H.G., van Eijck C.H., Kazemier G., Hop W.C., Greve J.W., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
45. Yeo C.J., Cameron J.L., Lillemoe K.D., Sohn T.A., Campbell K.A., Sauter P.K., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366